A randomized, single-blind, comparison of venlafaxine with paroxetine in elderly patients suffering from resistant depression

被引:21
|
作者
Mazeh, Doron
Shahal, Baruch
Aviv, Alex
Zemishlani, Hanna
Barak, Yoram
机构
[1] Y Abarbanel Mental Hlth Ctr, Psychogeriatr Ward A, IL-59100 Bat Yam, Israel
[2] Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel
关键词
elderly; paroxetine; resistant depression; venlafaxine;
D O I
10.1097/YIC.0b013e32817396ae
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
It is estimated that up to 45% of patients with depression do not have an adequate response to a first trial of antidepressant therapy with even higher reported rates for the elderly patients. To compare the efficacy and the tolerability of venlafaxine vs. paroxetine in elderly patients suffering from resistant major depression, who did not respond to at least two previous adequate trials of antidepressants. Patients entered an 8-week single-blind study. Patients were rated using the Clinical Global Impression Scale, Hamilton Rating Scale for Depression, and the Geriatric Depression Scale. Assessments were performed at baseline and on days 7, 14, 21, 28, 42 and 56. Side effects were recorded in a systemic manner. Thirty patients were included in the study, (17 women, 13 men; mean age=75.9 years, range: 68-83) and all had completed the 6-week trial. Mean dose of venlafaxine used was 165 mg/day (SD=73.8; range 75-300 mg). Mean dose of paroxetine used was 26 mg/day (SD=15.04; range 10-60 mg). Nine patients treated with venlafaxine (60%) and five patients treated with paroxetine (33%) remitted after 8 weeks of treatment. Four patients treated with venlafaxine and eight patients treated with paroxetine failed to respond. Significant improvement in Hamilton Rating Scale for Depression scores between baseline and endpoint were observed in both groups of patients. The mean Hamilton Rating Scale for Depression change for paroxetine was -12.5 and for venlafaxine -19.1 (P < 0.05). The mean Geriatric Depression Scale change for paroxetine was -3.2 and for venlafaxine -6.0 (P < 0.3). The mean Clinical Global Impression Scale change was -2.3 for paroxetine and -3.5 for venlafaxine (P < 0.05). Venlafaxine was significantly superior to paroxetine on Clinical Global Impression Scale and Hamilton Rating Scale for Depression measures. Side effects were transient and did not differ between treatment groups. Elderly depressed patients resistant to previous treatments had responded to a trial of paroxetine or venlafaxine. Remission rates were higher for venlafaxine and tolerability was acceptable for both compounds.
引用
收藏
页码:371 / 375
页数:5
相关论文
共 50 条
  • [1] Single-blind comparison of venlafaxine and nortriptyline in elderly major depression
    Gastó, C
    Navarro, V
    Marcos, T
    Portella, MJ
    Torra, M
    Rodamilans, M
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2003, 23 (01) : 21 - 26
  • [2] Venlafaxine and paroxetine in treatment-resistant depression - Double-blind, randomised comparison
    Poirier, MF
    Boyer, P
    BRITISH JOURNAL OF PSYCHIATRY, 1999, 175 : 12 - 16
  • [3] Comparison of the treatment with paroxetine and reboxetine in panic disorder: A randomized, single-blind study
    Bertani, A
    Perna, G
    Migliarese, G
    Di Pasquale, D
    Cucchi, M
    Caldirola, D
    Bellodi, L
    PHARMACOPSYCHIATRY, 2004, 37 (05) : 206 - 210
  • [4] A comparison of citalopram and paroxetine in the treatment of panic disorder: A randomized, single-blind study
    Perna, G
    Bertani, A
    Caldirola, D
    Smeraldi, E
    Bellodi, L
    PHARMACOPSYCHIATRY, 2001, 34 (03) : 85 - 90
  • [5] A randomized, double blind, comparison of venlafaxine ER and paroxetine in outpatients with moderate to severe major depression
    Casabona, GM
    Silenzi, V
    Guazzelli, M
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2002, 12 : S208 - S208
  • [6] A randomized, single-blind, comparison of duloxetine with bupropion in the treatment of SSRI-resistant major depression
    Rosso, G.
    Rigardetto, S.
    Bogetto, F.
    Maina, G.
    JOURNAL OF AFFECTIVE DISORDERS, 2012, 136 (1-2) : 172 - 176
  • [7] Comparison study of venlafaxine and paroxetine for the treatment of depression in elderly Chinese inpatients
    Hwang, JP
    Yang, CH
    Tsai, SJ
    INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 2004, 19 (02) : 189 - 190
  • [8] Double-blind, randomized comparison of mirtazapine and paroxetine in elderly depressed patients
    Schatzberg, AF
    Kremer, C
    Rodrigues, HE
    Murphy, GM
    AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2002, 10 (05): : 541 - 550
  • [9] A comparison of low-dose risperidone to paroxetine in the treatment of panic attacks: a randomized, single-blind study
    James M Prosser
    Samantha Yard
    Annie Steele
    Lisa J Cohen
    Igor I Galynker
    BMC Psychiatry, 9
  • [10] A comparison of low-dose risperidone to paroxetine in the treatment of panic attacks: a randomized, single-blind study
    Prosser, James M.
    Yard, Samantha
    Steele, Annie
    Cohen, Lisa J.
    Galynker, Igor I.
    BMC PSYCHIATRY, 2009, 9